Lanperisone formulation

Details Lanperisone formulation Lanperisone formulation

1996-09-26

1998-12-01

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424499, A61K 926, A61K 950

Patent

active

058434780

ABSTRACT:
A lanperisone hydrochloride compression-molded formulation comprising the first granules containing lanperisone hydrochloride and the second granules containing substantially no lanperisone hydrochloride but at least one pharmaceutical additive(s) selected from the group consisting of sugars, crystalline celluloses and cellulose derivatives is an excellent formulation which has a high storage stability because the decomposition of lanperisone hydrochloride is suppressed.

REFERENCES:
Database WPI, Section Ch, Week 9334, Derwent Publications Ltd., London, GB; Class B03, AN 93-269751 XP002020977 & JP-A-05 186 345 (Nippon Kayaku KK), 27 Jul. 1993 *abstract*.
Pharm Tech Japan vol. 7, No. 11 (1991) pp. 91(1311)-98(1318) and a partial English translation.

Affiliated with

Also associated with

Rating

Lanperisone formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lanperisone formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lanperisone formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2393630